ATE333510T1 - Enzymatische messung von mycophenolsäure - Google Patents

Enzymatische messung von mycophenolsäure

Info

Publication number
ATE333510T1
ATE333510T1 AT00935908T AT00935908T ATE333510T1 AT E333510 T1 ATE333510 T1 AT E333510T1 AT 00935908 T AT00935908 T AT 00935908T AT 00935908 T AT00935908 T AT 00935908T AT E333510 T1 ATE333510 T1 AT E333510T1
Authority
AT
Austria
Prior art keywords
mycophenolic acid
enzymatic measurement
measurement
present
biological samples
Prior art date
Application number
AT00935908T
Other languages
English (en)
Inventor
Allan R Dorn
Original Assignee
Roche Diagnostics Operations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Operations filed Critical Roche Diagnostics Operations
Application granted granted Critical
Publication of ATE333510T1 publication Critical patent/ATE333510T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9493Immunosupressants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00935908T 1999-06-09 2000-05-11 Enzymatische messung von mycophenolsäure ATE333510T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/328,741 US6107052A (en) 1999-06-09 1999-06-09 Enzymatic measurement of mycophenolic acid

Publications (1)

Publication Number Publication Date
ATE333510T1 true ATE333510T1 (de) 2006-08-15

Family

ID=23282234

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00935908T ATE333510T1 (de) 1999-06-09 2000-05-11 Enzymatische messung von mycophenolsäure

Country Status (8)

Country Link
US (1) US6107052A (de)
EP (1) EP1112373B1 (de)
JP (1) JP3854864B2 (de)
AT (1) ATE333510T1 (de)
CA (1) CA2339821C (de)
DE (1) DE60029413T2 (de)
ES (1) ES2267541T3 (de)
WO (1) WO2000075363A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524808B1 (en) * 1999-06-25 2003-02-25 Roche Diagnostics Corporation Enzyme inhibition immunoassay
US6811998B2 (en) * 1999-06-25 2004-11-02 Roche Diagnostics Operations, Inc. Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
EP1207394B1 (de) * 2000-11-14 2009-12-30 Roche Diagnostics GmbH Immunoassay für HIV-Protease-Hemstoffe
US7077859B2 (en) * 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
US6471980B2 (en) 2000-12-22 2002-10-29 Avantec Vascular Corporation Intravascular delivery of mycophenolic acid
US20050125054A1 (en) * 2000-12-22 2005-06-09 Avantec Vascular Corporation Devices delivering therapeutic agents and methods regarding the same
US20050203612A1 (en) * 2000-12-22 2005-09-15 Avantec Vascular Corporation Devices delivering therapeutic agents and methods regarding the same
US7083642B2 (en) * 2000-12-22 2006-08-01 Avantec Vascular Corporation Delivery of therapeutic capable agents
US20030050692A1 (en) * 2000-12-22 2003-03-13 Avantec Vascular Corporation Delivery of therapeutic capable agents
AU2002322719A1 (en) * 2001-07-26 2003-02-17 Avantec Vascular Corporation Delivery of therapeutic capable agents
US7276362B2 (en) * 2004-01-30 2007-10-02 Roche Diagnostics Operations, Inc. Recombinant histidine-tagged inosine monophosphate dehydrogenase polypeptides
JP2007532585A (ja) * 2004-04-26 2007-11-15 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ ミコフェノール酸及びそのエステル誘導体の調製方法
US20080009050A1 (en) * 2006-06-29 2008-01-10 Zdenek Pokluda Regulation of acid metabolite production
BRPI0803097A2 (pt) * 2007-04-11 2011-11-08 Teva Gyogyszergyar ... método para redução do nìvel de impurezas na fermentação do ácido micofenólico
CN113396226B (zh) * 2019-01-31 2025-03-25 豪夫迈·罗氏有限公司 氨检测测定中nadph或nadh的稳定化
CN112481354A (zh) * 2019-09-11 2021-03-12 上海云泽生物科技有限公司 一种霉酚酸检测试剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US5665583A (en) * 1988-08-12 1997-09-09 Arch Dev Corp Methods and materials relating to IMPDH and GMP production
US5283257A (en) * 1992-07-10 1994-02-01 The Board Of Trustees Of The Leland Stanford Junior University Method of treating hyperproliferative vascular disease
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5444072A (en) * 1994-02-18 1995-08-22 Syntex (U.S.A.) Inc. 6-substituted mycophenolic acid and derivatives
US5380879A (en) * 1994-02-18 1995-01-10 Syntex (U.S.A.) Inc. Derivatives of mycophenolic acid
US6225073B1 (en) * 1994-07-07 2001-05-01 Dade Behring Marburg Gmbh Immunoassay for mycophenolic acid
US5807876A (en) * 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
TR199802136T2 (xx) * 1996-04-23 2001-06-21 Vertex Pharmaceuticals Incorporated �MPDH enzimi inhibit�rleri olarak �re t�revleri.
US6153398A (en) * 1997-12-24 2000-11-28 The University Of Chicago Method to identify specific inhibitors of IMP dehydrogenase

Also Published As

Publication number Publication date
ES2267541T3 (es) 2007-03-16
WO2000075363A2 (en) 2000-12-14
CA2339821A1 (en) 2000-12-14
JP2003523730A (ja) 2003-08-12
EP1112373A2 (de) 2001-07-04
WO2000075363A3 (en) 2001-04-12
US6107052A (en) 2000-08-22
DE60029413T2 (de) 2007-02-22
DE60029413D1 (de) 2006-08-31
EP1112373B1 (de) 2006-07-19
CA2339821C (en) 2009-01-27
JP3854864B2 (ja) 2006-12-06

Similar Documents

Publication Publication Date Title
ATE333510T1 (de) Enzymatische messung von mycophenolsäure
DE60232323D1 (de) Verbessertes verfahren zum nachweis von atp
ATE377654T1 (de) Ubiquitin-ligase-assay
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
DE69429770D1 (de) Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays
ES2316597T8 (es) Instrumentos analíticos, biosensores y métodos
TR200000921T2 (tr) Bir sıvı mandıra ürünü içindeki analitlerin saptanması için tahlil cihazı
ATE384952T1 (de) Enzymhemmungsimmunverfahren
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
ATE347105T1 (de) Verfahren, assay und kit zur quantifizierung von hiv-proteasehemmer
PT918991E (pt) Metodo de ensaio
DE50115503D1 (de) Verfahren und mittel zur bestimmung von gesamthärte
ATE500505T1 (de) Enzymhemmungsimmunverfahren
DE69632826D1 (de) Nukleinsaeure erkennung von hepatitis gb virus
ATE272718T1 (de) Verfahren zur bestimmung von disaccharidasen
ATE333519T1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
DE60004840D1 (de) Allergennachweis
DE69032663D1 (de) Enzymtest und testsatz zur messung zellulärer aktivierung
ATE269417T1 (de) Verfahren zur erkennung und messung von gespleisten nukleinsäuren
ATE434668T1 (de) Methode zur messung von amylase aktivität
DE59910326D1 (de) Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren
ATE430317T1 (de) Enzymatische messung von imatinib-mesylat
DE60127941D1 (de) Versuchsaufbau zum messen von kobalamin und folsäure
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben
ATE449334T1 (de) Immobilisierte phosphatidsäuresonde

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1112373

Country of ref document: EP